US equities |
NVDA $236.84 ▲+1.24% SPCX $165.55 ▲+4.15% MU $1,064.77 ▼-0.94% TSLA $377.79 ▲+1.94% MSFT $526.24 ▲+1.68% INTC $116.51 ▼-2.36% SNDK $1,724.13 ▲+0.24% AMD $628.63 ▼-0.83%
FinancialContent

BeiGene, Ltd. - American Depositary Shares (NQ:BGNE)

184.71 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BeiGene, Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
From BeiGene
Via Business Wire
News headline image
BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
From BeiGene
Via Business Wire
News headline image
BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug List
From BeiGene
Via Business Wire
News headline image
Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer ↗
 
Via Benzinga
BeiGene Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
BeiGene Presents New Research from Tislelizumab Global Development Program at 2023 ASCO Gastrointestinal Cancers Symposium
From BeiGene
Via Business Wire
News headline image
These Were The Five Best And Worst Performing Large-Cap Stocks In Q4 2022 ↗
The year 2022 proved to be the worst calendar year for the S&P 500 since 2008. The benchmark index dropped more than 5% in December and almost 20% for the full year. Let’s take a look at the five best... 
Via Talk Markets
News headline image
BeiGene to Present at the J.P. Morgan 41st Annual Healthcare Conference
From BeiGene
Via Business Wire
What 5 Analyst Ratings Have To Say About BeiGene ↗
 
Via Benzinga
Will Investors Notice Exciting Sign On BeiGene's Chart? ↗
 
Via Benzinga
News headline image
Why Shares of BeiGene Were Up Wednesday ↗
The Chinese pharmaceutical stock is experiencing a comeback. 
Via The Motley Fool
News headline image
What 4 Analyst Ratings Have To Say About BeiGene ↗
Analysts have provided the following ratings for BeiGene (NASDAQ:BGNE) within the last quarter: 
Via Benzinga
News headline image
BeiGene Announces Acceptance of 12th Regulatory Submission in China for PD-1 Inhibitor Tislelizumab
From BeiGene
Via Business Wire
News headline image
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
News headline image
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific ↗
Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will... 
Via Talk Markets
News headline image
BeiGene’s BRUKINSA® (zanubrutinib) Demonstrated Superior Progression-Free Survival Over IMBRUVICA® (ibrutinib) in Chronic Lymphocytic Leukemia in Late-Breaker at ASH
From BeiGene
Via Business Wire
News headline image
PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday ↗
 
Via Benzinga
News headline image
BeiGene Calls for Greater Integration of Mental Health in Cancer Care After New Survey Reveals Gaps/Barriers for Patients and Survivors
From BeiGene
Via Business Wire
News headline image
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating ↗
On Thursday, China-based BeiGene stock cleared that desired 80-plus benchmark, with a jump to 82 from 77 a day earlier. 
Via Investor's Business Daily
News headline image
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115. 
Via Benzinga
News headline image
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket ↗
Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German... 
Via Benzinga
News headline image
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA® Versus IMBRUVICA® in Late-Breaking Oral Session at ASH 2022
From BeiGene
Via Business Wire
News headline image
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)
From BeiGene
Via Business Wire
News headline image
BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer Care
From BeiGene
Via Business Wire
News headline image
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
From BeiGene
Via Business Wire
News headline image
Tesla, Amazon, Coupang, Rivian, Beigene: Musk's Share Sale, Antitrust Lawsuit, Earnings Grab Retail Investors' Eyeballs ↗
Major Wall Street indices closed nearly 2% lower on Wednesday after the day was marred by uncertainties including the outcome of the mid-term elections and a sell-off in the cryptocurrency... 
Via Benzinga
News headline image
BeiGene Reports Third Quarter 2022 Financial Results
From BeiGene, Ltd.
Via Business Wire
News headline image
BeiGene to Present at Upcoming Investor Conferences
From BeiGene
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >